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FROM experimental and clinical observations it has long been known that
certain metals-such as nickel, arsenic and beryllium-may exhibit a carcinogenic
action. However, as a carcinogenic substance iron has attracted comparatively
scant attention. Nevertheless Kennaway and Kennaway (1936) demonstrated
that iron and steel grinders had 2.5 times as high an incidence of lung cancer as
the population at large. Faulds (1954) found that lung cancer had a prevalence
of 8.85 per cent (17 of 192) amongst iron mine workers. The latter figure may be
compared with an incidence oflung cancer in the total population of 1-85 per cent.
In spite of these previous findings, much comment ensued following Richmond's
(1959) report that sarcoma was induced in albino rats after intra-muscular injec-
tions of iron in the form of an iron-dextran complex (" Imferon "). His results
have been discussed at length in the light of their theoretical significance but also
and mainly on account of their repercussions on human medicine.
The tumours became apparent a fairly long time (8-16 months) after repeated
injections of large iron-dextran doses.
Whilst experiments on rats and mice (Haddow and Horning, 1960; Golberg,
Martin and Smith, 1960) have, experiments on rabbits (Haddow and Horning
1960) and dogs (Golberg, Martin and Smith, 1960) have not confirmed Richmond's
results. In a more comprehensive series of trials on mice, Haddow and Horning
(1960) have studied the carcinogenic action of, among other things, variousmetal
complexes. So far, however, most of the tested substances have shown no carci-
nogenic action, although various aluminium-dextran and copper-hydroxy
quinoline complexes have induced some sarcomas.
Richmond (1960) suggested that a, relationship exists between the local iron-
dextran dose and the incidence of tumours. Golberg, Martin and Smith's (1960)
observations also suggest that this is so. Richmond (1960) considered it obvious
that iron was the carcinogenic component of the complex. And, despite diligent
efforts, several workers have failed to induce tumours with low molecular weight
dextran alone. The presence of dextran could be a prerequisite for the penetration
of iron into the cells (phagocytosis). Whereas Richmond was unable to induce
sarcomas on mice after iron-saccharate complex, Haddow and Horning did observe
a few sarcomas in mice following injections of that substance.
The present investigation had for its aim to compare the carcinogenic actions
in the rat of intramuscular injections of three iron complexas of different types.
Apart from dissimilarities in chemical composition, these iron complexes deviated
with respect to molecular size. Partly owing to the latter deviation, the three
substances differed in their rates of absorption from the site of the injection.CARCINOGENIC ACTION OF IRON PREPARATIONS
Iron complexes
"Ferrigen" syn. "Astrafer" (Astra): A high molecular weight iron-carbo-
hydrate complex.* The average sedimentation constant has been determined
to be 47-5 ± 2.5 Svedberg units. Assuming that the molecules are spherical
with a density of 3-4 this corresponds to an average molecular weight of 230,000
(Eriksson).
"Imferon "(Pharmacia, Benger): A complex oflow molecular weight dextran
and iron.* Preliminary experiments indicate that the average sedimentation
constant of this preparation is 10 to 20 per cent smaller than that of" Ferrigen"
which with the assumptions mentioned gives an average molecular weight of
180,000 (Eriksson).
"Jectofer" (Astra) An iron-sorbitol-citric acid comples, stabilized with
dextrin.* The upper limit of the sedimentation constant has been found not
to exceed 8 to 9 Svedberg units. The average molecular weight has been esti-
mated to be less than 5,000 (Eriksson).
All the preparations have a concentration of 50 mg. iron per ml. and were
used without dilution.
MATERIALS AND METHODS
Albino rats of the Sprague-Dawley strain (Anticimex, Stockholm) were used
Initially the rats were about 40 days old and weighed between 60 and 80 g. They
were fed commercial rat bread reinforced with supplementary vitamins and salts.
The rats were injected (into the muscles ofthe right thigh) with rising doses twice
weekly for 4 months in accordance with the following schedule, in principle after
Richmond (1960).
Body weight
(g.)
Large dose, ml. .
Small dose, ml. .
<100
0-1
0- 05
100-150
0-2
0.1
150-200
0 3
0-15
>200
0'4
0 2
Mean total dose
per rat
(mng.)
510
255
Experimental groups
I Untreated control rats
II. Rats injected with large Iron-dextrin (Ferrigen) dose
III. Rats injected with small Iron-dextrin (Ferrigen) dose
IV. Rats injected with large Iron-dextran (Imferon) dose
V. Rats injected with small Iron-dextran (Imferon) dose
VI. Rats injected with small Iron-sorbitol (Jectofer) dose
VII. Rats injected with "Ferrigen" carbohydrate (dextrin) component in
amount corresponding to large dose.
Owing to the comparatively high toxicity of "Jectofer ", it could not be
administered in the high dose. Initially each group included some 40 rats, with
approximately equal numbers of males and females.
When the experiment had been in progress for a month, altogether 4 or 6 rats
from each group were killed at intervals of 3 or 4 weeks to facilitate observation
of any early lesions. At the autopsy, the muscles, all parenchymatous, lymphoid
*According to the manufacturer's specification.
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and endocrine organs, and bone marrow were saved. The specimens were fixed in
neutral formalin, embedded in paraffin in the usual manner, and stained in
accordance with van Gieson's technique and a modified Prussian blue procedure
due to Beutler, Robson and Butterwieser (1958).
In some of the rats the iron contents of muscles, liver, spleen and lymph
nodes were determined with the aid ofthe o-phenanthrolin method after the dried
tissues had been ashed with sulphuric acid.
RESULTS
After some weeks of injections, the injected thigh became swollen and seemed
rather tender in all groups receiving iron. In due course the swelling became
rather marked, particularly in those groups with "Imferon" and "Ferrigen" in
Treatment No. Exam.or Tumour occurence. Weeks after start. Total incid.
lot 38 40 42 44 46 48 50 52 54 56 58 6O 62 64 66 66 of tumour.
FERRIGEN,large dose 39 9 -H i- [- I1- F l 25/-30
FERRIGEN,small dose 39 8
IMFERON. large dose 39 10
IMFERON, small dose 39 8
JECTOFER. small dose 53 18
n~~~
-M 4, H FH H
HT:m r, F Eln n n
mF-flI-lnRn-FRnRH n
n
FIG. 1.-The incidence of tumours up to and including the 68th week.
large doses. On the other hand, the swelling was much smaller in the "Jectofer
group. After a few months of treatment, the skin of some of the rats in the
"Ferrigen" groups became necrotized and ulcerated, but such lesions would heal
spontaneously in a week or two.
When the injections were discontinued at the end of the fourth experimental
month, the local swelling diminished. Although it vanished almost completely in
the rats from the "Jectofer" group, a distinct induration persisted in the "Im-
feron" groups as well as in the "Ferrigen" groups.
Tumour development.-The incidence of tumours up to and including the 68th
week is shown in Table I and Fig. 1. The " lmferon "groups exhibited the highest
incidence of tumours, the time cf onset of tumours in the small dose group being
somewhat later than in the large dose group. But at the 68th week the two groups
showed the same total incidence. The males surviving from the group receiving
the large " Ferrigen "dose showed a similar high incidence oftumour development
However, the group treated with the small "Ferrigen " dose displayed a much
lower frequency of tumours which differed significantly from the group receiving
small "Imferon" doses (P < 0.01). Furthermore, after small "Ferrigen"
16/31
25/27
26/31
1/30
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doses the tumours tended to set in later than after large "Ferrigen" doses
(P < 0.01).
Moreover, in both "Ferrigen" groups the tumours showed a tendency to later
onsetthanineither ofthe" Imferon "groups. Inthisrespect a significant difference
exists between the combined Imferon" groups and the combined "Ferrigen"
groups (P < 0-001).
M9g. F/6.WET TISSUE
MUSCLE
20
15
10
4 7 10 16 20 26 WEEKS
FIG. 2.-Iron concentrations locally in muscular tissue varying lengths oftime after commence-
ment of injections of "small doses" of iron complexes. Mg. per g. wet tissue.
Jectofer. Imferon. Ferrigen.
Mg. Fe/ G.WET TISSUE
LIVER
4
2 11
4 7 10 16 20 26 WEEKS
FIG. 3.-Iron concentrations in liver varying lengths of time after commencment of injections
of" small doses" of iron complexes. Mg. per g. wet tissue.
Jectofer. Imferon. Ferrigen.
Among the rats in the "Jectofer" group a single tumour at injection site was
encountered in the 51st week (see below). No tumours were observed among the
controls or in the carbohydrate group.
The results of the iron determinations are shown graphically in Fig. 2 to 5.
The rate ofiron absorption from the site ofthe injection varied greatly among the
three iron complexes. "Ferrigen" exhibited a distinctly higher concentration at
the site ofthe injections after 4 to 6 months. Neither "Imferon "nor "Ferrigen"
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seemed to yield local iron concentrations that tended to decline after the cessation
of injections, although in this respect definite conclusions are not justified on the
basis of the available data.
The iron concentrations ofliver and spleen were much lower in the "Ferrigen"
groups than in the "Imferon" groups, where these levels were of the same order
as in the "Jectofer" group. The fact that, despite their superior absorption of
g. Fe/G. WET TISSUE
s SPLEEN
S
4
4 7 10 16 20 26 WEEKS
FIG. 4.-Iron concentrations in spleen varying lengths of time after commencement of injec-
tions of" small doses" of iron complexes. Mg. per g. wet tissue.
Jectofer. Imferon. lliFerrigen.
Mg. Fe/6.WET TISSUE·
LYMPH NOOES
6
4
2
4 7 10 16 20 26 WEEKS
FIG. 5.-Iron concentrations in lymph nodes varying lengths of time after commencement
of injections of" small doses" of iron complexes. Mg. per g. wet tissue.
Jectofer Imferon _lili J Ferrigen
iron from the site of the injection, the latter rats showed no higher iron levels in
liver and spleen than the rats in the "Imferon" groups might be because the low
molecular weight had enabled some of the "Jectofer" iron to be excreted via the
kidneys.
Histological observations
The early lesions were studied in 4 to 6 rats from each group which were killed
between 1 and 7 months after the commencement ofthe experiment. It was noted
that although the appearance of the histological reaction was basically the same
in all groups treated with iron, the rats inthe " Jectofer "group deviated distinctly
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from those in the other groups. As early as after the 1st month of injections the
rats in the "Imferon" and "Ferrigen" treated groups displayed a profuse
histiocytic reaction with accumulations interstitially in the muscles and, above all,
in foci in the surrounding adipose tissue of numerous macrophages charged with
phagocytized iron in abundance. This histiocytic reaction increased steadily up
to the 4th month, and at the same time fibrosis appeared interstitially and in the
perimuscular tissue. In several rats from the "Ferrigen "groups rather extensive
necrotic areas with abscess formation were encountered.
In slides stained with Prussian blue the iron was seen chiefly as large and small
granules in macrophages but also as a distinctly blue staining ofcollagen fibres and
vascular walls. However, the muscle fibres contained merely minute, inter-
fibrillar iron granules.
Between 4 and 6 months after the commencement of the experiment the
histiocytic reaction had become still more pronounced, and perhaps somewhat
more intense among rats from the "Ferrigen" treated groups than among those
receiving "Imferon ". Progressive fibrosis was observed both interstitially and in
the perimuscular adipose tissue. In some of the rats there appeared particularly
in the connective tissue a measure ofcellular polymorphism with some large nuclei
of irregular shape and occasional mitoses (Fig. 6 and 7).
The majority of the histiocytes had regular, small nuclei and abundant cyto-
plasm, but here and there patches of these cells would also exhibit some degree of
nuclear polymorphism.
Consistently and from the very beginning of the experiment those rats which
had been injected with "Jectofer" displayed a distinctly less intense histiocytic
reaction than those from the other groups. On the other hand, at an early stage
the amount of iron deposited in collagen tissue and vascular walls seemed greater
than in any of the other 4 groups receiving iron. The fibrosis, particularly that
occurring perimuscularly, appeared to be equally marked in the "Jectofer" rats
and in the rats from the other groups.
Tumour morphology.-The fully developed tumours were round, firm bodies
which over a period of2 to 5 weeks grewto the size ofan orange and often ulcerated
the skin. On being transected they were found fairly well circumscribed from the
surrounding muscles and adipose tissue. Centrally the larger ones invariably
exhibited necrotic foci with cystic degeneration. Large retroperitoneal metastases
were observed in two rats and pulmonary and pericardiac metastases were en-
countered in one rat. One ofthe metastatic tumours had been" Imferon "induced,
the two others were "Ferrigen" induced.
EXPLANATION OF PLATE
FIG. 6. Accumulations of large, pigment-containing macrophages in perimuscular adipose
tissue, 6 months after commencement of" Ferrigen" injections.
FIG. 7.-Intramuscular fibrosis and moderate nuclear polymorphism 8 months after commence-
ment of "Ferrigen" injections.
FIG. 8. Spindle cell sarcoma after "large dose" of "Imferon ".
FIG. 9.-Highly polymorphocellular sarcoma with "histiocytic" polynuclear giant cells
induced by "large dose" of" Ferrigen ".
FIG. 10. Muscular tissue infiltrated by predominantly spindle cell tumour tissue with abun-
dant mitoses, induced by "large dose" of" Imferon ".
FIG. 11.-Moderately cell-rich fibroma induced by "Jectofer ".
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At microscopic examination the tumours exhibited varying appearances. For
the most part the picture was that of a low-differentiated tissue with an abundance
of spindle cells, negligible collagen formation and fairly large numbers of mitoses
(Fig. 8). Marginally the tumours infiltrated muscles and fat (Fig. 10). Occasional
tumours were less rich in cells and distinctly collagen forming. Small areas with
a definitely more pronounced cellular polymorphism could be observed in the
majority of tumours. Some tumours exhibited a highly grotesque cellular poly-
morphism with large, often polynuclear cells containing giant nuclei and a pro-
fusely granulated cytoplasm, and large atypical mitoses (Fig. 9).
In the spindle celled tumours iron occurred predominantly in histiocytes
having small nuclei and abundant cytoplasm which were interspersed among the
tumour cells. Only minuscule quantities ofiron were to be seen in the tumour cells
themselves. Nevertheless, those tumours displaying the most accentuated cellular
polymorphism invariably exhibited the presence of iron pigment also in these
grotesquely polymorphic tumour cells.
The "Jectofer" induced tumour presented a deviating picture. Consistently
very poor in cells it exhibited small regular spindle cells without mitoses and lively
collagen formation. Hence it distinctly differed from the "Ferrigen" and "Im-
feron " induced tumours and, on a purely histological basis, it should be classified
more correctly as a fibroma (Fig. 11).
DISCUSSION
These results verify previous workers' observations regarding the carcinogenic
action ofintramuscularly administered iron-dextran. Moreover, they indicate that
an iron-dextrin complex exerts a similar action in principle. Richmond's (1959,
1960) and Haddow's (1959) assumptions that the carcinogenic action is bound to
the iron are thus borne out. Just as in their experiments, our trials have failed to
disclose any carcinogenic action ofthe isolated carbohydrate component (dextrin).
The correlation oftumour incidence to injected dose was not so obvious in the
present investigation. Yet a statistically significant difference pointing in that
direction was present between the groups treated with large and small " Ferrigen"
doses. In addition there was a tendency to later tumour onset in the groups
receiving small "Ferrigen " and "' Imferon "doses than in the corresponding high-
dosage groups.
When the incidence of tumours is related to the iron concentration at the site
of the injection, it appears that the number oftumours was definitely lower in the
small-dose "Ferrigen " group than in the small-dose "Imferon " group, notwith-
standing the fact that the local iron concentration of the muscles was higher in
the former group. In addition, the rats from the "Ferrigen" groups displayed a
later tumour onset than those from groups with corresponding dosages of
"Imferon ".
The local iron concentration in the muscles of the "Jectofer" treated rats
was clearly lower than intherats treated witheitherhighorlow doses of "Ferrigen "
and "Imferon ". Herein may lie the reason for the absencB of sarcomas in the
former group. Another possible prerequisite for the nondevelopment of sarcomas
might be the considerably less marked histiocytic reaction which, at least to some
extent, would seem to be a consequence ofthe low molecular weight of" Jectofer ".
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Needless to say, the development of a fibroma-like tumour in this group must have
been brought about by the injections.
Histogenesis.-In Richmond's opinion the tumours were most nearly classifiable
as histiocytomas and he apparently believed them to arise from those histiocytes
charged with iron pigment which proliferate in the muscle septa and perimuscular
connective tissue. He also demonstrated that the polymorphic giant cells encoun-
tered in some ofthese tumours are susceptible to silver impregnation by Marshall's
modification ofWeil-Davenport's method. This may indicate that such cells possess
histiocytic characteristics. Curiously enough, however, in the majority of tumours
iron pigment is rather sparse in the tumour tissue itself, and by far the greater
part of any pigment present is found in morphologically typical macrophages
lacking signs of cellular polymorphism. On the other hand, large amounts of iron
pigment are often encountered in the polymorphic giant cells.
In my experience, however, any cellular polymorphism seen in the "pre-
malignant "phase can be observed most distinctly in the fibrosis which is particu-
larly marked perimuscularly. Fibroblast-like, often polynuclear cellular elements
with irregular large nuclei and also some mitoses were encountered in such regions
some 6 to 9 months after the commencement of the experiment. The histiocytic
elements seemedtoexhibit aless conspicuous cellular polymorphism which, however,
was more difficult to judge owing to the abundance of pigment present in these
cells.
Accordingly the most prevalent tumour tissue component with densely packed
spindle cells should perhaps be interpreted as fibrosarcoma. Everything suggests,
however, that the designation histiocytic sarcoma is deserved by the highly poly-
morphic tumours with giant cells which often contain iron pigment and, according
to Richmond, are positive to Marshall's silver impregnation.
The collagen fibrils in the muscle septa and vascular walls at an early stage
consistently showed a uniformly intense, positive iron reaction. Consequently the
carcinogenic action ofiron can be exerted not only against the histiocytic cells butno
doubt also against the fibroblasts.
Mode of action of iron.-Since the carcinogenic action of iron can be induced
with the iron bound in different complexes, the iron component seems responsible
for this action. Conceivably the other component is essential merely as a mediator
facilitating the deposition of enough iron in the tissues and enabling it to be
retained and slowly absorbed so that a high and constant iron concentration is
maintained. Richmond expressed the view that the dextran component made it
easier for the iron to enter the cell. The histiocytic reaction is surely dependent
upon molecular size, and therefore upon molecular weight, and is unlikely to
occur below a given minimum molecular size. In conformity with this we have
found that "Jectofer "-whose molecular weight is much smaller than that of
either "Ferrigen" or "Imferon "-induces a distinctly less marked histiocytic
reaction by virtue of its smaller molecules than either of the other iron complexes
tested.
In view of the high incidence of tumours in the muscles, it is a remarkable
thing that tumours had not developed in the liver or spleen before the experiment
was discontinued. The concentration of iron, especially in the "Imferon" group,
was of the same order in the liver as in the muscles. Notably, however, the iron
content of the liver was histologically found mainly in groups of very large macro-
phages the majority ofwhich were located periportally, there being no appreciable
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amounts of iron deposited in the collagen, stroma or vascular walls. Nor did we
observe any proliferation of hepatic connective tissue, thus verifying the reports
of Golberg et al. (1960) Yet one would expect the chances for the development
of histiocytic tumours in the liver to be as great as at the site of the injection.
Conversely, if most of the tumours are interpreted as being of fibrosarcomatous
type, thenthe absence offibrosis inthe liver canwell bereconciled withtheabsence
of carcinogenic activity there. Haddow and Homrning (1960) observed occasional
hepatomas but reported no sarcomas or histiocytomas in the liver.
The mechanism of the carcinogenic action exerted by iron is of course just
as obscure as that exerted by other carcinogenic substances. Richmond and Had
dow discussed a variety ofconceivable points ofinterference with cellular function,
such as disturbed nucleic acid, vitamin E and haemoglobin metabolism or upsets
in various enzymatic systems. Hueper (1957) postulated that the formation of
macromolecular protein carcinogens might be a common denominator for the
action cfdifferent types of carcinogenic substances. It is remarkable that Hueper
also got tumours (in most cases malignant lymphomas) after injection in mice of
high molecular weight dextran of different degree of branching of the molecule
(Hueper, 1959).
SUMMARY
The carcinogenic actions of three different iron complexes intramuscularly
injected into rats have been studied. Both "Imferon" (iron dextran) and
"Ferrigen" (iron dextrin) induced a high incidence of sarcomas 9 to 14 months
after commencement of the injections, whereas "Jectofer" (iron-sorbitol-citric
acid) afterthe same length oftime induced but a singletumourwiththehistological
features ofa fibroma. The results are discussed inthe light of, among otherfactors,
the amount ofiron deposited and the differing molecular weights ofthe substances.
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